Gabriel Brooks

About Gabriel Brooks

Proven effective pharma/biotech executive. Responsible for efficiently guiding registration of new therapeutic and diagnostic agents, identification and analysis of novel targets and pathways for drug registration as well as expert in building effective clinical development organizations from the ground up. Led/leads - R&D clinical development from proof-of-concept studies and pre-clinical IND enabling studies to clinical phase zero through to Phase IV development. Guides efficient and targeted translational efforts of promising new drug entities into the clinic. Effective sponsor representative at face-to-face meetings with regulatory agencies including the FDA and EMA), supporting and driving development of reimbursement strategies (including representing the sponsor at face-to-face meeting with CMS/CAG). Deep experience in investor relations including governance, oversight, reporting and fundraising. Successful lead in both inbound as well as outbound asset transactions.

Experience

1. Chief Medical Officer

   Solid Biosciences

   Oct 2023 — Present · Boston, MA, US

   I am honored to be joining Solid Biosciences at this exciting time in their evolution from a Duchenne focused company to a true platform gene therapy company with a diversified pipeline of neuromuscular and cardiac programs.

Education

• Joan & Sanford I. Weill Medical College of Cornell University

  Doctor of Medicine - MD

• University of California, San Francisco

  Master's degree, Biostatistics Epidemiology

  2014 — 2015

• Weill Cornell Medical College

  Doctor of Medicine (M.D.), Medicine

  2002 — 2008

• Carnegie Mellon University

  Bachelor of Science (B.S.), Biology/Biological Sciences, General

  1995 — 2001

• St. Andrews School middletown

  HIgh School Diploma, High School

  1991 — 1995